Performance evaluation of Panbio^TM COVID-19 rapid antigen test for SARS-CoV-2 detection in a low prevalence cohort

Infect Dis (Lond). 2022 Dec;54(12):944-946. doi: 10.1080/23744235.2022.2100475. Epub 2022 Jul 15.

Authors

Tse-Hao Chen¹, Ming-Yuan Huang^{1

2}, Chien-Han Hsiao³, Ding-Kuo Chien^{1

2

4

5}, Weide Tsai^{1

2

4}

Affiliations

¹ Department of Emergency medicine, MacKay Memorial Hospital, Taipei, Taiwan.
² Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.
³ Department of Linguistics, Indiana University, Bloomington, IN, USA.
⁴ MacKay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan.
⁵ Institute of Mechatronic Engineering, National Taipei University of Technology, Taipei, Taiwan.

PMID: 35837988
DOI: 10.1080/23744235.2022.2100475

No abstract available

MeSH terms

Antigens, Viral
COVID-19 Testing
COVID-19* / diagnosis
Humans
Nasopharynx
Prevalence
SARS-CoV-2*
Sensitivity and Specificity

Substances

Antigens, Viral